|
C16ORF72 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.569220E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.587900E-02 |
| Normal-vs-Stage2 |
7.733600E-02 |
| Normal-vs-Stage3 |
9.638800E-01 |
| Normal-vs-Stage4 |
6.411000E-01 |
| Stage1-vs-Stage2 |
7.137600E-01 |
| Stage1-vs-Stage3 |
3.499600E-01 |
| Stage1-vs-Stage4 |
7.452600E-01 |
| Stage2-vs-Stage3 |
2.705200E-01 |
| Stage2-vs-Stage4 |
5.630000E-01 |
| Stage3-vs-Stage4 |
7.465800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.287800E-01 |
| Normal-vs-AfricanAmerican |
3.178400E-02 |
| Normal-vs-Asian |
1.332950E-01 |
| Caucasian-vs-AfricanAmerican |
8.227800E-02 |
| Caucasian-vs-Asian |
4.801400E-01 |
| AfricanAmerican-vs-Asian |
7.746200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.519820E-01 |
| Normal-vs-Female |
3.372800E-01 |
| Male-vs-Female |
8.050000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.168000E-02 |
| Normal-vs-Extreme_Weight |
3.454300E-02 |
| Normal-vs-Obese |
9.005000E-01 |
| Normal-vs-Extreme_Obese |
3.439600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.832000E-01 |
| Normal_Weight-vs-Obese |
2.783600E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.206000E-01 |
| Extreme_Weight-vs-Obese |
5.744000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.398800E-01 |
| Obese-vs-Extreme_Obese |
3.138400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.900200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.888600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.830410E-01 |
| Normal-vs-Age(81-100Yrs) |
4.538300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.016400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.062800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.932100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.575200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.722070E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.935800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.220200E-01 |
| Normal-VS-Type2 PRCC |
1.079970E-01 |
| Normal-VS-KIRP CIMP |
3.378200E-01 |
| Normal-VS-Unclassified PRCC |
6.013400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.270200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.103600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.131000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.623230E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.615400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.415000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.756410E-03 |
| Normal-vs-N1 |
4.736400E-01 |
| Normal-vs-N2 |
4.227400E-01 |
| N0-vs-N1 |
1.554490E-02 |
| N0-vs-N2 |
5.475000E-01 |
| N1-vs-N2 |
4.889000E-01 |
|
|
